| Product NDC: | 43386-660 |
| Proprietary Name: | Trimethobenzamide Hydrochloride |
| Non Proprietary Name: | Trimethobenzamide Hydrochloride |
| Active Ingredient(s): | 300 mg/1 & nbsp; Trimethobenzamide Hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 43386-660 |
| Labeler Name: | GAVIS Pharmaceuticals, LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA076546 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20110117 |
| Package NDC: | 43386-660-24 |
| Package Description: | 100 CAPSULE in 1 BOTTLE (43386-660-24) |
| NDC Code | 43386-660-24 |
| Proprietary Name | Trimethobenzamide Hydrochloride |
| Package Description | 100 CAPSULE in 1 BOTTLE (43386-660-24) |
| Product NDC | 43386-660 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Trimethobenzamide Hydrochloride |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20110117 |
| Marketing Category Name | ANDA |
| Labeler Name | GAVIS Pharmaceuticals, LLC |
| Substance Name | TRIMETHOBENZAMIDE HYDROCHLORIDE |
| Strength Number | 300 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Antiemetic [EPC],Emesis Suppression [PE] |